The approval of novel orphan drug designations continues to grow, while many existing rare disease therapies are receiving approval for expanded indications.…

mergers and acquisitions

Nationwide Coalition Opposes Express Scripts/Medco Merger

Merck, MedImmune deal space

Pandemic offers AstraZeneca a blockbuster return

Eli Lilly drops $64M to buy SGX

Despite holdouts, Roche has Ventana